| Membership Information | Meeting Information | Officers | News |
| Awards | ByLaws | Newsletters | Annual Report |

Meeting Information

October 2007 Annual Meeting Presentations

Challenges of Abuse Liability Evaluation During Drug Development and Approval of New Compounds—Richard H. Alper, Ph.D.

Abuse Potential Assessment: FDA Perspective—Michael Klein, Ph.D.

Preclinical Approaches to Abuse Liability Assessment—S. Stevens Negus

What is Addiction and How Do We Treat It?—Roger D. Weiss, M.D.

Contact SOT HQ for further questions.